BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 11184118)

  • 1. The relationship between modifiable health risks and group-level health care expenditures. Health Enhancement Research Organization (HERO) Research Committee.
    Anderson DR; Whitmer RW; Goetzel RZ; Ozminkowski RJ; Dunn RL; Wasserman J; Serxner S;
    Am J Health Promot; 2000; 15(1):45-52. PubMed ID: 11184118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Projecting future medical care costs using four scenarios of lifestyle risk rates.
    Leutzinger JA; Ozminkowski RJ; Dunn RL; Goetzel RZ; Richling DE; Stewart M; Whitmer RW
    Am J Health Promot; 2000; 15(1):35-44. PubMed ID: 11184117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association between health risks and medical expenditures in a Japanese corporation.
    Lynch WD; Chikamoto Y; Imai K; Lin TF; Kenkel DS; Ozminkowski RJ; Goetzel RZ
    Am J Health Promot; 2005; 19(3 Suppl):238-48. PubMed ID: 15675538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gender-specific effects of modifiable health risk factors on coronary heart disease and related expenditures. HERO Research Committee. Health Enhancement Research Organization.
    Wasserman J; Whitmer RW; Bazzarre TL; Kennedy ST; Merrick N; Goetzel RZ; Dunn RL; Ozminkowski RJ
    J Occup Environ Med; 2000 Nov; 42(11):1060-9. PubMed ID: 11094784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The predictive validity of the HERO Scorecard in determining future health care cost and risk trends.
    Goetzel RZ; Henke RM; Benevent R; Tabrizi MJ; Kent KB; Smith KJ; Roemer EC; Grossmeier J; Mason ST; Gold DB; Noeldner SP; Anderson DR
    J Occup Environ Med; 2014 Feb; 56(2):136-44. PubMed ID: 24451607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between modifiable health risks and health care expenditures. An analysis of the multi-employer HERO health risk and cost database.
    Goetzel RZ; Anderson DR; Whitmer RW; Ozminkowski RJ; Dunn RL; Wasserman J;
    J Occup Environ Med; 1998 Oct; 40(10):843-54. PubMed ID: 9800168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ten Modifiable Health Risk Factors and Employees' Medical Costs-An Update.
    Goetzel RZ; Henke RM; Head MA; Benevent R; Rhee K
    Am J Health Promot; 2020 Jun; 34(5):490-499. PubMed ID: 32295381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ten modifiable health risk factors are linked to more than one-fifth of employer-employee health care spending.
    Goetzel RZ; Pei X; Tabrizi MJ; Henke RM; Kowlessar N; Nelson CF; Metz RD
    Health Aff (Millwood); 2012 Nov; 31(11):2474-84. PubMed ID: 23129678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using an ounce of prevention: does it reduce health care expenditures and reap pounds of profits? A study of the financial impact of wellness and health risk screening programs.
    Phillips JF
    J Health Care Finance; 2009; 36(2):1-12. PubMed ID: 20499716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical cost savings for web-based wellness program participants from employers engaged in health promotion activities.
    Williams LC; Day BT
    Am J Health Promot; 2011; 25(4):272-80. PubMed ID: 21361813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of worksite wellness intervention on cardiac risk factors and one-year health care costs.
    Milani RV; Lavie CJ
    Am J Cardiol; 2009 Nov; 104(10):1389-92. PubMed ID: 19892055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health risks and group-level health care expenditures.
    Golaszewski T
    Am J Health Promot; 2000; 15(1):53-4. PubMed ID: 11184119
    [No Abstract]   [Full Text] [Related]  

  • 13. A more generalizable method to evaluate changes in health care costs with changes in health risks among employers of all sizes.
    Musich S; White J; Hartley SK; Bhattarai GR; Hawkins K; Ozminkowski RJ
    Popul Health Manag; 2014 Oct; 17(5):297-305. PubMed ID: 24892950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A more generalizable method to evaluate the association between commonly reported health risks and health care expenditures among employers of all sizes.
    White J; Hartley SK; Musich S; Hawkins K; Ozminkowski RJ
    J Occup Environ Med; 2013 Oct; 55(10):1179-85. PubMed ID: 24064775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An evaluation of the Well at Dell health management program: health risk change and financial return on investment.
    Musich S; McCalister T; Wang S; Hawkins K
    Am J Health Promot; 2015; 29(3):147-57. PubMed ID: 25559251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health promotion and disease prevention: a look at demand management programs.
    Fronstin P
    EBRI Issue Brief; 1996 Sep; (177):1-14. PubMed ID: 10161533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corporate smoking cessation on Long Island.
    Mulligan P
    Health Promot Pract; 2010 Mar; 11(2):182-7. PubMed ID: 18480319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Financial impact of health promotion programs: a comprehensive review of the literature.
    Aldana SG
    Am J Health Promot; 2001; 15(5):296-320. PubMed ID: 11502012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between modifiable health risks and future medical care expenditures: the Korea Medical Insurance Corporation (KMIC) Study.
    Jee SH; O'Donnell MP; Suh I; Kim IS;
    Am J Health Promot; 2001; 15(4):244-55. PubMed ID: 11349346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimating risk reduction required to break even in a health promotion program.
    Ozminkowski RJ; Goetzel RZ; Santoro J; Saenz BJ; Eley C; Gorsky B
    Am J Health Promot; 2004; 18(4):316-25. PubMed ID: 15011932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.